medigraphic.com
Revista Médica Sinergia

2021, Number 01

<< Back Next >>

Revista Médica Sinergia 2021; 6 (01)

Cardiovascular risk associated to menopause

Bolaños CBD, Ortega ME

Language: Spanish
References: 15
Page: 1-12
PDF size: 196.52 Kb.


ABSTRACT

Cardiovascular disease represents one of the main causes of mortality in postmenopausal women. After menopause, there are many factors that increase the real risk of cardiovascular disease, including smoking, high blood pressure, dyslipidemias, type two diabetes mellitus, age at menarche and menopause, and vasomotor symptoms, in addition, the traditional risk factors of the transition period, such as decreased glucose tolerance and endothelial dysfunction. Also, other factors are included, such as primary ovarian dysfunction and surgical menopause, which usually advance all the physiological processes of a natural menopause, resulting in a significant increase in cardiovascular risk.


REFERENCES

  1. Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health 2019; 4: e553– 64. https://doi.org/10.1016/S2468-2667(19)30155-0

  2. Muka T, Oliver-Williams C, Colpani V, Kunutsor S, Chowdhury S, et al. (2016) Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis. PLOS ONE 11(6): e0157417. https://doi.org/10.1371/journal.pone.0157417

  3. P. Collins, C. M. Webb, T. J. de Villiers, J. C. Stevenson, N. Panay & R. J. Baber (2016) Cardiovascular risk assessment in women – an update, Climacteric, 19:4, 329-336. https://doi.org/10.1080/13697137.2016.1198574

  4. Arteaga Urzúa E. Menopausia y riesgo cardiovascular. Rev Med Chil. 2016 Nov;144(11):1375-1376. http://dx.doi.org/10.4067/S0034-98872016001100001

  5. Bernhardt L, Lawson CA. Early menopause and risk of cardiovascular disease: an issue for young women. Lancet Public Health. 2019 Nov;4(11): e539-e540. https://doi.org/10.1016/ S2468-2667(19)30184-7

  6. Zhao D, Guallar E, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, Lima JA, Allison MA, Shah SJ, Bertoni AG, Budoff MJ, Post WS, Michos ED. Endogenous Sex Hormones and Incident Cardiovascular Disease in Post- Menopausal Women. J Am Coll Cardiol. 2018 Jun 5;71(22):2555-2566. https://doi.org/10.1016/j.jacc.2018.01.083

  7. Fonseca, M.I.H., da Silva, I.T. & Ferreira, S.R.G. Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?. Diabetol Metab Syndr 9, 22 (2017). https://doi.org/10.1186/s13098-017-0221-5

  8. de Kat, A.C., Dam, V., Onland-Moret, N.C. et al. Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC Med 15, 2 (2017). https://doi.org/10.1186/s12916-016-0762-8

  9. Honigberg MC, Zekavat SM, Aragam K, et al. Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. JAMA. 2019;322(24):2411–2421. https://doi.org/10.1001/jama.2019.19191

  10. Biglia N, Cagnacci A, Gambacciani M, Lello S, Maffei S, Nappi RE. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? Climacteric. 2017 Aug;20(4):306-312. http://dx.doi.org/10.1080/13697137.2017.1315089

  11. Cagnacci A, Palma F, Romani C, Xholli A, Bellafronte M, Di Carlo C. Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women?. Gynecological Endocrinology 2015; 31:5, 359- 362. https://doi.org/10.3109/09513590.2014.998188

  12. Franco OH, Muka T, Colpani V, Kunutsor S, Chowdhury S, Chowdhury R, Kavousi M. Vasomotor symptoms in women and cardiovascular risk markers: Systematic review and meta-analysis. Maturitas 81 (2015) 353-361. http://dx.doi.org/10.1016/j.maturitas.2015.04.016

  13. Abbas SZ, Sangawan V, Das A, Pandey AK. Assessment of Cardiovascular Risk in Natural and Surgical Menopause. Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):223-228. https://doi.org/10.4103/2230-8210.232384

  14. Naftolin F, Friedenthal J, Nachtigall R and Nachtigall L. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment. F1000Research 2019, 8(F1000 Faculty Rev):1576. https://doi.org/10.12688/f1000research.15548.1

  15. Boardman HMP, Hartley L, Eisinga A, Main C, Roqué i Figuls M, Bonfill Cosp X, Gabriel Sanchez R, Knight B. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD002229. https://doi.org/10.1002/14651858.CD002229.pub4




2020     |     www.medigraphic.com